Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

SIB-1508Y exerts neuroprotective effects in addition to beneficial motor/cognitive actions

Oct. 22, 1998

Animal studies with KW-6002, a novel therapeutic for PD, presented at international congress

Oct. 22, 1998

Elevated levels of homocysteine a potential risk factor in AD

Oct. 22, 1998

Toyama licenses neuroprotective compound from Senju

Oct. 22, 1998

Lomerizine, a new antimigraine agent, compared to flunarizine in rats

Oct. 22, 1998

Dopaminergic and serotonergic agents synthesized at Lundbeck

Oct. 22, 1998

NOS inhibitors developed at Chugai reportedly useful for cerebrovascular disorders

Oct. 22, 1998

Pramipexole improves rest tremor in Parkinson's disease

Oct. 22, 1998

Linopirdine analogue proves to be more potent neurotransmitter release enhancer

Oct. 21, 1998

Versed Syrup approved for pediatric sedation

Oct. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026